Metabolic Response to Food in Lung Cancer

Study summary

This goal of this study is to describe how unintentional weight loss influences fasting and post-prandial metabolic flexibility in participants with advanced non-small cell lung cancer.

Ask AI to explain this study

Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedWeight loss (%)

The study team can explain what participation involves.

Who it may be forNon-small cell lung cancer (NSCLC)

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Sep 17, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Terminated

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Observational

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Pennington Biomedical Research Center

Study sponsor

Study overview

What this study is about

Purpose: Not specified
Study type: Observational
Phase: Not applicable
Sponsor: Pennington Biomedical Research Center
Interventions being studied: Other: Weight loss (%)

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Cancer type

Non-small cell lung cancer (NSCLC)→

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

Age greater than or equal to 18 years
Diagnosis of non-small-cell lung cancer
Reported weight stability or loss after cancer diagnosis
Body mass index less than or equal to 35 kilograms per meter squared
Ability to provide written informed consent
Willing and able to comply with all scheduled visits, treatment plans, lab tests, and other study procedure
Allow the collection and storage of biospecimens and data for future use

Reasons someone may not be able to joinExclusion criteria

Prior diagnosis of diabetes mellitus (type 1 or type 2)
Currently pregnant or breastfeeding
Contraindication to consuming the liquid mixed meal
Any medications affecting gastric motility
Any other condition that, in the investigator's opinion, would preclude participation or successful compliance with the protocol

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

Pennington Biomedical Research CenterBaton Rouge, Louisiana

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Sep 17, 2026. Always confirm current availability with the study team.

View original record ↗